Impinj target price raised to $195 from $168 by Needham
PI•Needham raised its target price for Impinj to $195 from $168.
Related News
Rafael Holdings subsidiary Cyclo Therapeutics seeks FDA approval for remibetadex to treat NPC
RFL•
Unifi fully repays $55.5 million debt balance
UFI•
Switzerland's Novocure Q3 revenue rises 16%, beats estimates
NVCR•
XTI Aerospace reaches non-binding agreement to restructure $4.5 million in debt
XTIA•
Crocs Q3 revenue beats estimates on international growth
CROX•